Baird Medical Investment HolBDMD
13F holders, Q4 2024 (December 31)6holders
$6.53avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Baird Medical Investment Hol (BDMD) in their 13F filings. The largest holders were Highbridge Capital Management LLC ($855K), Periscope Capital Inc. ($623K) and Scientech Research LLC ($421K).
- Company
- Baird Medical Investment Hol
- CUSIP
- G0705H103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.0M |
| Exits | 0 | $0 |
Ownership 6 holders
| Highbridge Capital Management LLC | 0.12% | New | 112,500 | $855K |
| Periscope Capital Inc. | 0.52% | New | 125,000 | $623K |
| Scientech Research LLC | 0.12% | New | 55,453 | $421K |
| Geode Capital Management, LLC | 0.00% | New | 10,838 | $82K |
| UBS Group AG | 0.00% | New | 1,406 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 297 | $2K |
"% of holder's portfolio" is BDMD's weight in each manager's 13F, not the share of Baird Medical Investment Hol the manager owns.